tirzepatide cardiovascular outcomes and in Patients With Ventricular Tachycardia and Systolic Heart Failure Effect of Tirzepatide on Cardiovascular

For patients currently in compounded GLP-1 programs, the transition would likely involve one of several options: switching to an FDA-approved branded medication (at substantially higher cost), discussing alternative weight management approaches with a licensed provider, or exploring whether 503A patient-specific compounding applies to their individual clinical situation

As shown by Batchuluun at al., metformin and liraglutide improve high glucose-induced oxidative stress via inhibition of PKC-NADPH oxidase pathway in human aortic endothelial cells

Baseline HbA1c is one of the strongest predictors of response

Can't wait to share this study with you